Tag: Irish healthcare concerns
John Whelan: Trump’s Generic Drug Tariff Plan Raises Concerns in Ireland
As President Trump’s proposed tariff on generic drugs moves forward, Irish stakeholders express deep concerns about its implications for health care and the pharmaceutical industry in Ireland.
Concerns Emerge in Ireland Over Trump’s Generic Drug Tariff Plan
John Whelan discusses the implications of Trump's generic drug tariff plan, raising alarms in Ireland about potential impacts on healthcare and access to essential medicines.
